In addition, BRCA has also been described as a metabolic regulator through its complex interactions with insulin/IGF-1 signaling axis and as transcriptional repressor of the gene IGF1R, main key players in the pathogenesis of T2DM-related complications and in breast cancer onset and progression [68,70]. This evidence concerns the gene IGF1R and type 2 diabetes mellitus.